Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 14, 2018 - Issue
Submit an article Journal homepage
62
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Factors related to improvement of symptoms, function, and caregiver burden in Chinese patients with schizophrenia after switching to paliperidone palmitate once-monthly from oral antipsychotics

Nan Li1 Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, People’s Republic of China
,
Yu Feng2 Regional Medical Affairs, Janssen Pharmaceutical Companies of Johnson and Johnson, Singapore
,
Huafei Lu3 Medical Affairs, Xian Janssen Pharmaceutical Ltd, Beijing, People’s Republic of China
,
Shang Li Cai3 Medical Affairs, Xian Janssen Pharmaceutical Ltd, Beijing, People’s Republic of China
,
Jianmin Zhuo4 Department of Statistics, Janssen China Research and Development, Shanghai, People’s Republic of China
,
Tianmei Si5 National Clinical Research Center for Mental Disorders and The Key Laboratory of Mental Health, Ministry of Health (Peking University), Beijing, People’s Republic of China;6 Peking University Institute of Mental Health (The Sixth Hospital), Beijing, People’s Republic of ChinaCorrespondence[email protected]
&
Lili Zhang3 Medical Affairs, Xian Janssen Pharmaceutical Ltd, Beijing, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 825-837 | Published online: 22 Mar 2018

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Ning Ma, Lei Zhang, Wufang Zhang, Yingying He, Chong Ye & Xin Li. (2023) Long-Acting Injectable Antipsychotic Treatment for Schizophrenia in Asian Population: A Scoping Review. Neuropsychiatric Disease and Treatment 19, pages 1987-2006.
Read now
Takashi Ohnishi, Akihide Wakamatsu & Hisanori Kobayashi. (2021) Early Improvement of Psychiatric Symptoms with Long-Acting Injectable Antipsychotic Predicts Subsequent Social Functional Remission in Patients with Schizophrenia. Neuropsychiatric Disease and Treatment 17, pages 1095-1104.
Read now

Articles from other publishers (3)

Rebekka Lencer, Maria Paz Garcia-Portilla, Paul Bergmans, Srihari Gopal, Maju Mathews, Annette Wooller & Katalin Pungor. (2021) Impact on carer burden when stable patients with schizophrenia transitioned from 1-monthly to 3-monthly paliperidone palmitate. Comprehensive Psychiatry 107, pages 152233.
Crossref
Zh. B. Bibekova, E. A. Strel’cov & A. S. Makarchuk. (2020) APPLICATION OF ANTIPSYCHOTICS OF LONG-TERM ACTION IN SCHIZOPHRENIA. Medical Herald of the South of Russia 11:1, pages 6-13.
Crossref
Tian Mei Si, Yi long Zhang, Yu Feng, Jian Min Zhuo, Shangli Cai & Lili Zhang. (2019) Association between symptom control and functional improvement in patients with acute schizophrenia: A post hoc analysis of an open-label, single-arm, multi-center study of paliperidone-extended release formulation. Psychiatry Research 274, pages 301-305.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.